eScholarship
metadata only
CC BY
Deep Functional and Molecular Characterization of a High‐Risk Undifferentiated Pleomorphic Sarcoma
Nonrhabdomyosarcoma soft-tissue sarcomas (STSs) are a class of 50+ cancers arising in muscle and soft tissues of children, adolescents, and adults. Rarity of each subtype often precludes subtype-specific preclinical research, leaving many STS patients with limited treatment options should frontline
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma#867657
- Cryoablation for Advanced Bone and Soft Tissue Tumors#896030
- Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors#411376
- The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions#651926
- A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma#905158
Record · ID 1328428
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive